[1] SOBIECKAM, LEWANDOWSKA K,JKOBER J, et al. Can a new scoring system improve prediction of pulmonary hypertension in newly recognised interstitial lung diseases?[J]. Lung,2020,198(3):1235-1240.
[2] CERIBELLI A, ISAILOVIC N, SANTIS M, et al. Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies[J]. J Autoimmun,2020,3(11):563-568.
[3] HUANG H L, LIN W C, YE C C, et al. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy[J]. J Clin Neurosci,2020,74(25):852-857.
[4] JBEATON T, GILLIS D, MORWOOD K, et al. Granulomatous lymphocytic interstitial lung disease: limiting immunosuppressive therapy—a single-centre experience[J]. Resp Med,2020,8(5):812-816.
[5] 中华医学会呼吸病学分会. 特发性肺 (间质) 纤维化诊断和治疗指南(草案)[J]. 中华结核和呼吸杂志,2002,25(7):387-389.
[6] 易祥华.非特异性间质性肺炎病理诊断中国专家共识(草案)[J]. 中华结核和呼吸杂志,2018,41(11):833-839.
[7] 王丽娟,杨旭燕,汪慧.结缔组织病肺间质病变的诊治进展[J]. 细胞与分子免疫学杂志,2011,27(1):115-117.
[8] TAKATANI A, KOGA T, FUJITA Y, et al. Efficacy of tofacitinib for slowly progressive interstitial lung disease in a patient with anti-MDA5 antibody-positive dermatomyositis[J]. Clin Immunol,2020,215(26):2654-2659.
[9] BRIOUDES E, ALIBASHE-AHMED M, LAVA V,et al. Syndecan-4 is regulated by IL-1β in β-cells and human islets[J]. Mol Cell Endocrinol,2020,510(23):2105-2109.
[10] 赵芳哲,桑晓青,朱彦,等.M2型巨噬细胞促分泌的IL-6因子对成纤维细胞活化的作用机制研究[J]. 药学学报,2019,10(44):1-11.
[11] 孙盼盼,侯雅鑫,张宇瞳,等.苦参碱对PRRSV/LPS共刺激诱导小鼠炎症反应的作用[J]. 中国兽医杂志,2019,55(8):40-45,130.
[12] 赵玉月,连宏建,李姗,等.B细胞活化因子对自身免疫性疾病引起的寻常型间质性肺炎与特发性肺纤维化的鉴别诊断[J]. 中华结核和呼吸杂志,2018,41(7):544-550. |
